Author
Maria A. González-Carmona
Also Known As
Dr. Maria A. Gonzalez-Carmona, M Gonzalez-Carmona, M. A. Gonzalez-Carmona, M. Gonzalez-Carmona, M.A. Gonzalez-Carmona, M.A. González-Carmona, MARIA A. GONZALEZ-CARMONA, MARIA GONZALEZ-CARMONA, Maria A Gonzalez-Carmona, Maria A González-Carmona
179
Publications
2.5K
Citations
24
H-Index
68
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 12 | 14 | 914 |
2 | Health Sciences | 2 | 2 | 114 |
3 | Engineering | 1 | 1 | 25 |
4 | Natural Sciences | 1 | 1 | 10 |
5 | Biochemistry | 1 | 1 | 10 |
Maria A. González-Carmona
×
45
Publications
2K
Citations
23
H-Index
| Year | Citations | |
|---|---|---|
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial Shukui Qin, Minshan Chen, Ann‐Lii Cheng, Surgical OncologyHepatologyMedicinePathologyHigh-risk Hepatocellular Carcinoma | 2023 | 415 |
2019 | 150 | |
2014 | 124 | |
2016 | 81 | |
2019 | 81 | |
2017 | 71 | |
2018 | 71 | |
2008 | 67 | |
2020 | 62 | |
2020 | 57 |
Page 1
Page 1